Table 3.

Proportion of ART facilities that met WHO EWI targets, aggregated by additional programmatic/ facility characteristics, Tanzania, 2010

		EWI 1a, ART prescribing practices	EWI 2, patients LTFU at 12 months	EWI 3a, retention on 1st line ART at 12 months	EWI 5b, Clinic appointment keeping in first 12 months
		WHO target: 100%	WHO target: ≤ 20%	WHO target: ≥ 70%	WHO target: ≥ 80%
	Frequency	n (%)	n (%)	n (%)	n (%)
Average opening time (hours)
Clinic & pharmacy: ≥ 8 hrs	29	29 (100)	16 (55)	10 (35)	0 (0)
Clinic & pharmacy: < 8 hrs	6	6 (100)	1 (17)	0 (0)	1 (17)
			p = 0.177	p = 0.640	p = 0.171
Average distance (kilometers, km) travelled by patient
≥ 51 km	10	10 (100)	5 (50)	3 (30)	1 (10)
21-50 km	10	10 (100)	5 (50)	3 (30)	0 (0)
11-20 km	8	8 (100)	6 (75)	3 (38)	0 (0)
≤ 10 km	7	7 (100)	1 (14)	1 (14)	0 (0)
			p = 0.162	p = 0.885	p = 1.000
Average time (minutes) patient spent at the Clinic
>180 minutes	6	6 (100)	6 (100)	5 (83)	0 (0)
60-180 minutes	15	15 (100)	7 (47)	3 (20)	1 (7)
< 60 minutes	14	14 (100)	4 (29)	2 (14)	0 (0)
			p = 0.011*	p = 0.007*	p = 1.000
Supplementary ART dispensing locations
Refill, outreach or both	5	5 (100)	2 (40)	2 (40)	0 (0)
Neither	30	30 (100)	15 (50)	8 (27)	1 (3)
			p = 1.000	p = 0.610	p = 1.000
Home based services
Yes	25	25 (100)	13 (52)	6 (24)	1 (4)
No	10	10 (100)	4 (40)	4 (40)	0 (0)
			p = 0.711	p = 0.421	p = 1.000

*Statistically significant.

EWI 1a, % of adult patients initiating ART at the site* who are initially prescribed, or who initially pick up from the pharmacy, an appropriate first-line ART regimen.

EWI 2, % of patients initiating ART at the site* who are lost to follow-up (LTFU) 12 months after ART initiation.

EWI 3a, % of adult patients initiating ART at the site* who are taking an appropriate first-line ART regimen 12 months later.

EWI 5b, % of patients initiating ART at the site* who attended all scheduled or expected clinical consultations on time during the first 12 months.